About Cohizon Life Sciences Limited
Data last updated:
Cohizon Life Sciences Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Sona Company Pte. Ltd. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 17 September 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH1983PLC030874. Its GSTIN is 27AAACS6498M1ZL (Maharashtra). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹11.02 Cr and a paid-up capital of ₹3.18 Cr. It was formerly known as Sajjan Impex Pvt Limited and Sajjan Impex Limited. It is led by directors including Chandra Bose Bhardwaj (Whole-Time Director) and Steven Andre J Buyse.
Its last annual general meeting (AGM) was held on 20 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,008.66 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹45.29 Cr (net margin 4.5%) and EBITDA of ₹86.04 Cr (EBITDA margin 8.5%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 3% over five years.
The company has about 960 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹355.7 Cr and satisfied charges of ₹152.85 Cr on record. Court records list 49 cases involving the company, including 15 filed by the company and 34 filed against it; 6 cases are pending. The company has 7 deals on record (7 secondary share transfers); the latest was in October 2024. Its 9 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is Indo Amines Limited with revenue of ₹1,093.83 Cr. The company has 8 MSME Form 1 returns on record between 2023 and 2024, listing 2,608 overdue payments to 114 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sajjan.com.
Company details
Name history
Cohizon Life Sciences has undergone 2 name changes throughout its history. The company was previously known as Sajjan Impex Pvt Limited, and Sajjan Impex Limited. The current legal name is Cohizon Life Sciences Limited.
| Company Name | Status |
|---|---|
| Cohizon Life Sciences Limited | Current |
| Sajjan Impex Pvt Limited | Previous |
| Sajjan Impex Limited | Previous |
CIN history
Cohizon Life Sciences has one previous CIN (Corporate Identification Number): U51900MH1983PTC030874. The current CIN is U51900MH1983PLC030874, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51900MH1983PLC030874 | Current |
| U51900MH1983PTC030874 | Previous |
Contact details
Cohizon Life Sciences Limited's registered office is in Mumbai, Maharashtra. Its website is sajjan.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressUrmi Estate Tower A 14th Floor 95 Ganpatrao Kadam Marg Lower Parel (W, ), Mumbai, Maharashtra, India – 400013
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Cohizon Life Sciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cohizon Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cohizon Life Sciences Limited, buy the company report.
Financials of Cohizon Life Sciences Limited
FY 2025 filings availableCohizon Life Sciences Limited reported revenue of ₹1,008.66 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1,008.66 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹86.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45.29 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.5% | ||||
| Net Profit Margin | 4.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cohizon Life Sciences Limited, buy the company report.
Board of directors and KMP of Cohizon Life Sciences Limited
Cohizon Life Sciences Limited currently reports 9 directors and 1 key managerial person. 27 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Srivastava Also directs: Agathon Business and Consultancy LLP | Ceo | 17 Apr 2024 | 2 Years 6 Months | Current |
| Steven Andre J Buyse | Director | 25 May 2022 | 4 Years 4 Months | Current |
| Anant Jain Also directs: CVC Advisers (India) Private Limited | Director | 25 May 2022 | 4 Years 4 Months | Current |
| Rajan Hamir Gajaria Also directs: Advanta Enterprises Limited | Director | 22 Feb 2024 | 2 Years 8 Months | Current |
| Anurag Surana Also directs: Privi Speciality Chemicals Limited, Neogen Chemicals Limited, Yasho Industries Limited and 4 more | Director | 25 Nov 2023 | 2 Years 10 Months | Current |
| Dirk Backhaus | Director | 26 Jun 2024 | 2 Years 3 Months | Current |
Peer comparison
Cohizon Life Sciences Limited is compared with the 9 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Indo Amines Limited | ₹1,093.83 Cr (FY 2025) | 14.0% | Thane, Maharashtra, India | |||
| Gacl-Nalco Alkalies & Chemicals Private Limited | ₹1,089.97 Cr (FY 2025) | 37.0% | Vadodara, Gujarat, India | |||
| Performance Specialty Products (India) Private Limited | ₹1,082.8 Cr (FY 2025) | 5.0% | Gurgaon, Haryana, India | |||
| Acutaas Chemicals Limited | ₹1,023.8 Cr (FY 2025) | 41.0% | Surat, Gujarat, India | |||
| Prasol Chemicals Limited | ₹1,015.53 Cr (FY 2025) | 14.0% | Navi Mumbai, Maharashtra, India | |||
| Cohizon Life Sciences Limitedthis company | ₹1,008.66 Cr (FY 2025) | ₹45.29 Cr | 4.5% | -9.0% | 960 | Mumbai, Maharashtra, India |
| Clean Science and Technology Limited | ₹1,005.23 Cr (FY 2025) | 21.0% | Pune, Maharashtra, India | |||
| Croda India Company Private Limited | ₹988.8 Cr (FY 2025) | 10.0% | Navi Mumbai, Maharashtra, India | |||
| Viswaat Chemicals Limited | ₹981.5 Cr (FY 2025) | 27.0% | Mumbai, Maharashtra, India | |||
| Archroma India Private Limited | ₹931.79 Cr (FY 2025) | 23.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Cohizon Life Sciences Limited, buy the company report.
Auditor
Cohizon Life Sciences Limited is audited by Deloitte Haskins & Sells LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Deloitte Haskins & Sells LLP | FY 2025 | 117366W/W-100018 |
Shareholding
The shareholding of Cohizon Life Sciences Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cohizon Life Sciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2025 | 101247569 | Others | ₹70.38 Lakh | Open | |
| 09 Jun 2025 | 101113011 | Axis Bank Limited | ₹50 Cr | Open | |
| 13 Nov 2024 | 101010324 | Others | ₹50 Cr | Open | |
| 14 Jun 2023 | 100735282 | Axis Bank Limited | ₹150 Cr | Open | |
| 04 Jan 2020 | 100351195 | Others | ₹30 Cr | Open |
To see the full charge records of Cohizon Life Sciences Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Cohizon Life Sciences Limited has 7 deals on record (7 secondary share transfers); the latest was in October 2024.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2024 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| May 2022 | Secondary share transfer | Undisclosed | Buyer: CVC Capital Partners, Sona Company Pte Limited & Mohit Goyal, Sona Company Pte Limited & Anant Jain Seller: Supriyata Capital Private Limited , Priyata International, 2 individuals |
| Jan 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2021 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| Dec 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Madhav Prasad Agarwal HUF |
To see the full deal history of Cohizon Life Sciences Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cohizon Life Sciences Limited has 49 court cases on record: 15 filed by Cohizon Life Sciences, 34 filed against it. 6 cases are pending and 43 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 42 | 32 | 5 |
| High courts | 6 | 2 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 49)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Civil suit | Filed by the company against individuals | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed against the company by an individual | Pending |
| District court, Bharuch, Gujarat | Court case (RECO33C2 LC) | Filed against the company by an individual | Pending |
| District court, Bharuch, Gujarat | Court case (RECO33C2 LC) | Filed against the company by an individual | Pending |
| District court, Bharuch, Gujarat | Court case (REFER T LC) | Filed against the company by an individual | Pending |
To see the full case history of Cohizon Life Sciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Cohizon Life Sciences Limited has 8 MSME Form 1 returns on record between 2023 and 2024, listing 2,608 overdue payments to 114 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 114)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| B.B.Chemicals Private Limited | |||
| an individual supplier | |||
| Om Enterprise | |||
| Kamal Insulation Engineers Private Limited |
To see the full MSME payment records of Cohizon Life Sciences Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Cohizon Life Sciences Limited has a workforce of 960 employees on its EPFO records as of Sep 26, 2025, across 2 active EPFO establishments.
GST
Cohizon Life Sciences has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACS6498M1ZL | Maharashtra | Active | 01 Jul 2017 |
| 27AAACS6498M2ZK | Maharashtra | Active | 23 Jan 2018 |
| 24AAACS6498M1ZR | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cohizon Life Sciences Limited, buy the company report.
Recent activity
Cohizon Life Sciences Limited has 38 board changes on record since 2009: 12 appointments and 26 cessations. The latest: Chandra Bose Bhardwaj ceased to be Additional Director on 17 Jun 2025.
57 earlier events are in the company report.
Frequently asked questions
Cohizon Life Sciences is an active public limited company based in Mumbai, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 17 September 1983 (43+ years old) and is registered under CIN U51900MH1983PLC030874.
Cohizon Life Sciences has 10 current directors and KMP:
- Chandra Bose Bhardwaj - Whole-Time Director
- Steven Andre J Buyse - Director
- Anant Jain - Director
- Rajan Hamir Gajaria - Director
- Anurag Surana - Director
- Dirk Backhaus - Director
- Siddharth Tapaswin Patel - Director
- Amit Soni - Director
- Neha Sureka - Additional Director
- Rajesh Kumar Srivastava - Ceo
The latest financial statements of Cohizon Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cohizon Life Sciences is 27AAACS6498M1ZL, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 27AAACS6498M2ZK (Maharashtra), 24AAACS6498M1ZR (Gujarat).
The CIN (Corporate Identification Number) of Cohizon Life Sciences is U51900MH1983PLC030874. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cohizon Life Sciences has 49 court cases on record: 15 filed by the company and 34 filed against it. 6 are pending. Most are in the district courts.
Cohizon Life Sciences was incorporated on 17 September 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.
Cohizon Life Sciences has 7 deals on record (7 secondary share transfers); the latest was in October 2024.
The peers of Cohizon Life Sciences by revenue are Indo Amines Limited, Gacl-Nalco Alkalies & Chemicals Private Limited, Performance Specialty Products (India) Private Limited, Acutaas Chemicals Limited, Prasol Chemicals Limited and 4 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chandra Bose Bhardwaj ceased to be Additional Director on 17 Jun 2025. Chandra Bose Bhardwaj was appointed as Whole-Time Director on 27 May 2025. Neha Sureka was appointed as Additional Director on 26 Feb 2025. Cohizon Life Sciences has 38 board changes on record in total.
Cohizon Life Sciences has 8 MSME Form 1 returns on record between 2023 and 2024, listing 2,608 overdue payments to 114 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Cohizon Life Sciences can be reached through the website sajjan.com. Its registered office is in Mumbai, Maharashtra, India.